There are 2004 cancer immunotherapies crowding into the pipeline. Now what? – Endpoints News
|
There are 2004 cancer immunotherapies crowding into the pipeline. Now what?
Endpoints News Before raising the issue, the CRI — which specializes in immunotherapies — wanted to present a clear picture of the scene to everyone in the field. By assigning two tumor immunologists to comb through a variety of global trial databases over a year's … |
